Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
925448-08-6
|
| gptkbp:developedBy |
gptkb:Sirtris_Pharmaceuticals
|
| gptkbp:function |
SIRT1 activator
|
| gptkbp:hasInChIKey |
QZKQZQJQKQKQKQ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C20H18N4O2
|
| gptkbp:hasSMILES |
CN(C)C=CC(=O)Nc1ccccc1-c2ccn3ncc(C4=CC=CN=C4)cc3c2
|
| https://www.w3.org/2000/01/rdf-schema#label |
SRT-392
|
| gptkbp:investigatedBy |
metabolic disorders
|
| gptkbp:IUPACName |
(E)-N-(2-(3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidin-6-yl)phenyl)-3-(dimethylamino)acrylamide
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL2105727
25185745 |
| gptkbp:relatedTo |
SRT-1460
SRT-1720 SRT-2183 |
| gptkbp:synonym |
SRT392
|
| gptkbp:bfsParent |
gptkb:Dodge_SRT
|
| gptkbp:bfsLayer |
7
|